Catarina Dias-Freitas

Lisbon, Portugal

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Targeting Lung Cancer Metabolism: Therapeutic Opportunities and Challenges.

Targeting Lung Cancer Metabolism: Therapeutic Opportunities and Challenges.

Journal: Advances in experimental medicine and biology
Published: July 11, 2026

Cell-Free DNA (cfDNA), Its Applications in Cancer Diagnosis and Monitoring, and Its Potential Role in Regulating Cancer Metabolism.

Cell-Free DNA (cfDNA), Its Applications in Cancer Diagnosis and Monitoring, and Its Potential Role in Regulating Cancer Metabolism.

Journal: Advances in experimental medicine and biology
Published: July 11, 2026

Use of Nuclear Magnetic Resonance (NMR) to Study Cancer Metabolism.

Use of Nuclear Magnetic Resonance (NMR) to Study Cancer Metabolism.

Journal: Advances in experimental medicine and biology
Published: July 11, 2026

Polycationic dendrimers synergizes with gefitinib to overcome EGFREx19Del-driven resistance in non-small-cell lung cancer.

Polycationic dendrimers synergizes with gefitinib to overcome EGFREx19Del-driven resistance in non-small-cell lung cancer.

Journal: Discover oncology
Published: September 04, 2025

Targeting TNBC: core-shell polycationic polyurea dendrimers with inherent anticancer activity.

Targeting TNBC: core-shell polycationic polyurea dendrimers with inherent anticancer activity.

Journal: FEBS open bio
Published: March 17, 2025

Cell-Free DNA (cfDNA) Regulates Metabolic Remodeling in the ES-2 Ovarian Carcinoma Cell Line, Influencing Cell Proliferation, Quiescence, and Chemoresistance in a Cell-of-Origin-Specific Manner.

Cell-Free DNA (cfDNA) Regulates Metabolic Remodeling in the ES-2 Ovarian Carcinoma Cell Line, Influencing Cell Proliferation, Quiescence, and Chemoresistance in a Cell-of-Origin-Specific Manner.

Journal: Metabolites
Published: February 25, 2025

Cell-Free DNA (cfDNA) Regulates Metabolic Remodeling, Sustaining Proliferation, Quiescence, and Migration in MDA-MB-231, a Triple-Negative Breast Carcinoma (TNBC) Cell Line.

Cell-Free DNA (cfDNA) Regulates Metabolic Remodeling, Sustaining Proliferation, Quiescence, and Migration in MDA-MB-231, a Triple-Negative Breast Carcinoma (TNBC) Cell Line.

Journal: Metabolites
Published: February 25, 2025

Metabolic profiling and combined therapeutic strategies unveil the cytotoxic potential of selenium-chrysin (SeChry) in NSCLC cells.

Metabolic profiling and combined therapeutic strategies unveil the cytotoxic potential of selenium-chrysin (SeChry) in NSCLC cells.

Journal: Bioscience reports
Published: June 12, 2024

Interaction between NSCLC Cells, CD8+ T-Cells and Immune Checkpoint Inhibitors Potentiates Coagulation and Promotes Metabolic Remodeling-New Cues on CAT-VTE.

Interaction between NSCLC Cells, CD8+ T-Cells and Immune Checkpoint Inhibitors Potentiates Coagulation and Promotes Metabolic Remodeling-New Cues on CAT-VTE.

Journal: Cells
Published: January 03, 2024
Showing 1-9 of 9

Last Updated: 09/26/2026